SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-020812
Filing Date
2020-11-09
Accepted
2020-11-09 16:01:48
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 932918
2 ex31-1.htm EX-31.1 19318
3 ex31-2.htm EX-31.2 18414
4 ex32.htm EX-32 12768
5 form10-q_001.jpg GRAPHIC 89930
  Complete submission text file 0001493152-20-020812.txt   4460379

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abeo-20200930.xsd EX-101.SCH 30119
7 XBRL CALCULATION FILE abeo-20200930_cal.xml EX-101.CAL 48054
8 XBRL DEFINITION FILE abeo-20200930_def.xml EX-101.DEF 98520
9 XBRL LABEL FILE abeo-20200930_lab.xml EX-101.LAB 262087
10 XBRL PRESENTATION FILE abeo-20200930_pre.xml EX-101.PRE 199859
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 712004
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 201297623
SIC: 2834 Pharmaceutical Preparations